From GlobeNewswire: 2025-04-14 15:45:00

Diagnos Inc. provides additional information on the amendment to convertible debentures, with insider Mr. André Larente owning $20,000 in convertible debentures. If converted, Mr. Larente would own 2.15% of the total issued Common Shares. The amendment is exempt from certain valuation and approval requirements, approved by the board of directors to benefit DIAGNOS and its shareholders. The amendment is pending TSX Venture Exchange acceptance and formal documentation execution. Diagnos is focused on early detection of eye-related health issues using AI technology to improve diagnostic accuracy and patient outcomes globally.



Read more at GlobeNewswire: DIAGNOS Provides Additional Information on Amendment to